These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 18373433)

  • 1. Sensitivity of HIV type 1 primary isolates to human anti-CD40 antibody-mediated suppression is related to coreceptor use.
    Abayneh SA; Ellmark P; Karlsson U; Andersson H; Borrebaeck CA; Karlsson I; Fenyö EM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):447-52. PubMed ID: 18373433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a strongly activating human anti-CD40 antibody that suppresses HIV type 1 infection.
    Ellmark P; Andersson H; Abayneh S; Fenyö EM; Borrebaeck CA
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):367-73. PubMed ID: 18327984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is decreased HIV-1 infectivity of placental macrophages caused by high levels of beta-chemokines?
    Meléndez J; García V; Sánchez E; Delgado R; Torres G; Meléndez-Guerrero LM
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL51-9. PubMed ID: 11936874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
    Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
    J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD40 ligand induces beta-chemokine production by macrophages and resistance to HIV-1 entry.
    di Marzio P; Mariani R; Lui R; Thomas EK; Landau NR
    Cytokine; 2000 Oct; 12(10):1489-95. PubMed ID: 11023663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
    Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D
    J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
    Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
    Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40-activated macrophages become highly susceptible to X4 strains of human immunodeficiency virus type 1.
    Bakri Y; Mannioui A; Ylisastigui L; Sanchez F; Gluckman JC; Benjouad A
    AIDS Res Hum Retroviruses; 2002 Jan; 18(2):103-13. PubMed ID: 11839143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of CCR5-tropic HIV type 1 infection by OX40 stimulation via enhanced production of β-chemokines.
    Tanaka R; Takahashi Y; Kodama A; Saito M; Ansari AA; Tanaka Y
    AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1147-54. PubMed ID: 20854204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?
    Lathey JL; Brambilla D; Goodenow MM; Nokta M; Rasheed S; Siwak EB; Bremer JW; Huang DD; Yi Y; Reichelderfer PS; Collman RG
    J Leukoc Biol; 2000 Sep; 68(3):324-30. PubMed ID: 10985247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages.
    Perez-Bercoff D; David A; Sudry H; Barré-Sinoussi F; Pancino G
    J Virol; 2003 Apr; 77(7):4081-94. PubMed ID: 12634367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
    Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
    Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines.
    Margolis LB; Glushakova S; Grivel JC; Murphy PM
    J Clin Invest; 1998 May; 101(9):1876-80. PubMed ID: 9576751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms.
    McDyer JF; Dybul M; Goletz TJ; Kinter AL; Thomas EK; Berzofsky JA; Fauci AS; Seder RA
    J Immunol; 1999 Mar; 162(6):3711-7. PubMed ID: 10092834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV type 1 infection with a RANTES-IgG3 fusion protein.
    Challita-Eid PM; Klimatcheva E; Day BT; Evans T; Dreyer K; Rimel BJ; Rosenblatt JD; Planelles V
    AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1617-24. PubMed ID: 9870314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of RANTES on the infection of monocyte-derived primary macrophages by human immunodeficiency virus type 1 and type 2.
    Ylisastigui L; Amzazi S; Bakri Y; Vizzavona J; Vita C; Gluckman JC; Benjouad A
    Biomed Pharmacother; 1998; 52(10):447-53. PubMed ID: 9921414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
    Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
    J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble glycosaminoglycans Do not potentiate RANTES antiviral activity on the infection of primary macrophages by human immunodeficiency virus type 1.
    Ylisastigui L; Bakri Y; Amzazi S; Gluckman JC; Benjouad A
    Virology; 2000 Dec; 278(2):412-22. PubMed ID: 11118364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to C-C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1.
    Bouhlal H; Hocini H; Quillent-Grégoire C; Donkova V; Rose S; Amara A; Longhi R; Haeffner-Cavaillon N; Beretta A; Kaveri SV; Kazatchkine MD
    J Immunol; 2001 Jun; 166(12):7606-11. PubMed ID: 11390517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.